Martingale Asset Management »

Terns Pharmaceuticals shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $229k 83k 2.76
2024-12-31 $544k 98k 5.54
2024-09-30 $618k 74k 8.34
2023-12-31 $100k 16k 6.49